MCET has been a very good reporting company, dot's all the i's and crosses all the t's. They are otcqb and not pinksheet. http://www.otcmarkets.com/stock/MCET/quote I have been with them since 2001 when they were EXTI, before they found the incredible cells that sent them down this path to drug discovery. They are an upstanding company and we've seen a new path being developed to provide income and get their drugs to market. I've stayed with them because of the large number of patents and the science, they have been so good with their required filings, and only issue important PRs. I had very good feelings from the special shareholders meeting that they are going to be ramping up efforts big time in the next 6-12 months. I'm very excited.
Market Data 
Markets 
